Shanghai Labway Clinical Laboratory Co.Ltd(301060) march 28 issued the annual report of 2021. During the reporting period, the company achieved an operating revenue of 1.778 billion yuan, with a year-on-year increase of 43.62%; the net profit was 204 million yuan, with a year-on-year increase of 84.68%; Deduct non net profit of 182 million yuan, an increase of 72.39% year-on-year. The company also issued a profit distribution plan of 3 yuan for 10 shares.
Shanghai Labway Clinical Laboratory Co.Ltd(301060) is a comprehensive service provider providing overall solutions for the inspection and diagnosis industry. The company provides third-party medical examination and pathological diagnosis services, in vitro diagnosis products of well-known brands at home and abroad and other professional technical support to medical institutions at all levels to meet the differentiated needs of medical institutions at all levels. After more than ten years of development, the company has formed a systematic, large-scale and networked service system. Taking the independent medical laboratory as the regional center, the system promotes the standardized construction of grass-roots medical laboratories by optimizing the allocation of medical testing and pathological diagnosis resources and integrating the output of the regional center service system, so as to realize the mutual recognition of medical testing results and the collaborative sharing of pathological diagnosis resources in the region. During the reporting period, the company’s main businesses included “medical diagnostic services” and “sales of in vitro diagnostic products”.
